Abstract Details
|
Activity Number:
|
632
|
|
Type:
|
Topic Contributed
|
|
Date/Time:
|
Thursday, August 7, 2014 : 10:30 AM to 12:20 PM
|
|
Sponsor:
|
Biopharmaceutical Section
|
|
Abstract #313300
|
View Presentation
|
|
Title:
|
Implementation of NGS Genomics Data in Oncology Clinical Trials: Analytical Issues and Lessons Learned
|
|
Author(s):
|
Ray Liu*+ and Feng Gao and Jacob Zhang
|
|
Companies:
|
Takeda and Takeda and Takeda
|
|
Keywords:
|
NGS ;
biomarker ;
clinical trial
|
|
Abstract:
|
Cancer is a highly complex and heterogeneous disease that is hard to treat. Next generation sequencing (NGS)-based technology has the potential to provide comprehensive genomics information on short turnaround time that can lead to better patient selection and ultimately personalized treatment decision. However, many unique practical and analytical issues need to be considered carefully when adapting NGS-based genomics data into oncology clinical trials. In this presentation we will share the experience and lessons learned, which can be used to better design future NGS-based clinical trials.
|
Authors who are presenting talks have a * after their name.
Back to the full JSM 2014 program
|
2014 JSM Online Program Home
For information, contact jsm@amstat.org or phone (888) 231-3473.
If you have questions about the Professional Development program, please contact the Education Department.
The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.
Copyright © American Statistical Association.